| Vikram Sharma, | |
|
1100 Reid Pkwy, Richmond, IN 47374-1157 | |
| (765) 983-3000 | |
| Not Available |
| Full Name | Vikram Sharma |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 8 Years |
| Location | 1100 Reid Pkwy, Richmond, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235792680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MT217197 (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | 01088843A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reid Hospital & Health Care Services | Richmond, IN | Hospital |
| Harrison Medical Center | Bremerton, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Sound Inpatient Physicians Pllc | 5991618738 | 309 |
| Reid Physician Associates, Inc. | 6406910769 | 338 |
News Archive
It's official: sugar is not so sweet—for our health, that is. The new study "Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults," published in JAMA Internal Medicine, examines the intake of "added sugars," and the results suggest that sugar is now an independent risk factor for heart disease and other chronic diseases.
UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.
A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.
› Verified 5 days ago
| Entity Name | South Sound Inpatient Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023285756 PECOS PAC ID: 5991618738 Enrollment ID: O20031107000668 |
News Archive
It's official: sugar is not so sweet—for our health, that is. The new study "Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults," published in JAMA Internal Medicine, examines the intake of "added sugars," and the results suggest that sugar is now an independent risk factor for heart disease and other chronic diseases.
UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.
A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.
› Verified 5 days ago
| Entity Name | Cogent Healthcare Of Washington, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861430522 PECOS PAC ID: 2062306350 Enrollment ID: O20040209000839 |
News Archive
It's official: sugar is not so sweet—for our health, that is. The new study "Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults," published in JAMA Internal Medicine, examines the intake of "added sugars," and the results suggest that sugar is now an independent risk factor for heart disease and other chronic diseases.
UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.
A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.
› Verified 5 days ago
| Entity Name | Hospitalist Medicine Physicians Of Washington-tcg |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699253195 PECOS PAC ID: 6800148495 Enrollment ID: O20181009003329 |
News Archive
It's official: sugar is not so sweet—for our health, that is. The new study "Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults," published in JAMA Internal Medicine, examines the intake of "added sugars," and the results suggest that sugar is now an independent risk factor for heart disease and other chronic diseases.
UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.
A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vikram Sharma, 1100 Reid Pkwy, Richmond, IN 47374-1157 Ph: (765) 935-8802 | Vikram Sharma, 1100 Reid Pkwy, Richmond, IN 47374-1157 Ph: (765) 983-3000 |
News Archive
It's official: sugar is not so sweet—for our health, that is. The new study "Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults," published in JAMA Internal Medicine, examines the intake of "added sugars," and the results suggest that sugar is now an independent risk factor for heart disease and other chronic diseases.
UPMC Health Plan today announced a joint initiative with BL Healthcare to address the issues of access to quality healthcare and rising healthcare costs by using technology to provide remote care over broadband. UPMC Health Plan will leverage BL Healthcare's next generation remote monitoring platform to provide unique and innovative services to their members.
A new study in the January 2011 issue of Health Affairs is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.
NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).
A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice.
› Verified 5 days ago
Dr. Erica Michelle Kretchman, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Reid Pkwy, Suite 300, Richmond, IN 47374 Phone: 765-935-8941 Fax: 765-935-8578 | |
Justin Varghese, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Reid Pkwy, Richmond, IN 47374 Phone: 765-983-3000 | |
Dr. John E Mcginty Iv, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Reid Pkwy, Suite 210, Richmond, IN 47374 Phone: 765-962-1337 Fax: 765-966-0858 | |
Magdy Z Rofail, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1080 University Blvd, Richmond, IN 47374 Phone: 765-939-2037 | |
Robert B. Bode, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1471 Chester Blvd Ste A, Richmond, IN 47374 Phone: 765-935-4088 Fax: 765-966-2596 | |
James Edward Swonder, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 N 15th St, Richmond, IN 47374 Phone: 765-966-0521 Fax: 765-966-3345 | |
David W Smith, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1080 University Blvd, Richmond, IN 47374 Phone: 765-939-2037 |